HEPION PHARMACEUTICALS, INC. Property, Plant and Equipment
HEPION PHARMACEUTICALS, INC. (HEPA) had Property, Plant and Equipment of $0 as of 2024-03-31, per its 10-Q filed 2024-05-21.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2025-04-08
- 2024-03-31: Property, Plant and Equipment, Net $0.00.
- 2023-12-31: Property, Plant and Equipment, Net $29.49K.
- 2023-09-30: Property, Plant and Equipment, Net $41.09K.
- 2023-06-30: Property, Plant and Equipment, Net $60.77K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-21 |
| 2023-12-31 | $29.49K 10-K · filed 2025-04-08 |
| 2023-09-30 | $41.09K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $60.77K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $63.75K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $81.62K 10-K · filed 2024-04-16 |
| 2022-09-30 | $82.99K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $106.03K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $131.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $152.77K 10-K · filed 2023-04-10 |
| 2021-09-30 | $176.19K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $162.81K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $172.40K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $108.44K 10-K · filed 2022-04-08 |
| 2020-09-30 | $45.48K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $52.68K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $48.45K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $57.17K 10-K · filed 2021-03-31 |
| 2019-09-30 | $57.57K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $64.84K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $65.64K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $32.43K 10-K · filed 2020-05-14 |
| 2018-09-30 | $37.08K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $41.72K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $46.36K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $56.59K 10-K · filed 2019-03-14 |
| 2017-09-30 | $61.57K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $67.56K 10-KT · filed 2018-03-26 |
| 2017-03-31 | $71.64K 10-Q · filed 2017-04-12 |
| 2016-12-31 | $79.99K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $73.79K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $80.85K 10-KT · filed 2018-03-26 |
| 2016-03-31 | $71.92K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $77.32K 10-Q · filed 2016-02-12 |
| 2015-09-30 | $82.72K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $81.44K 10-K · filed 2016-09-28 |
| 2015-03-31 | $86.61K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $62.09K 10-Q · filed 2015-02-12 |
| 2014-09-30 | $55.58K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $14.53K 10-K · filed 2015-09-25 |
| 2014-03-31 | $15.85K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |